Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) that require polyetheramine functionalities. Its structure supports conjugation in drug delivery systems, especially in modifying pharmacokinetic properties of therapeutic compounds. Also employed in the preparation of chelating agents and functional polymers due to its amine and ether groups, which enhance solubility and binding characteristics. Commonly found in research settings for modifying biomolecules and in the creation of specialty chemicals for diagnostic applications.